Bayer | BAYN - Operating Expenses


Bayer reported EUR9.88B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Air Liquide EUR 10.37B 6.15B Dec/2025
Akzo Nobel EUR 2.13B 23M Mar/2026
Alcon AG USD 2.41B 4M Mar/2026
Amarin USD 51.48M 113K Dec/2025
Arkema EUR 2.1B 20.9M Mar/2026
AstraZeneca USD 8.18B 4.35B Mar/2026
BASF EUR 14.62B 410M Mar/2026
Bayer EUR 9.88B 452M Mar/2026
Beiersdorf EUR 4.16B 212M Dec/2025
Corteva USD 3.75B 650.92M Mar/2026
Covestro EUR 3.24B 5.46B Dec/2025
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.34B 63M Mar/2026
Genmab DKK 798M 235M Dec/2025
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 5.34B 1.85B Mar/2026
GRIFOLS EUR 1.45B 255.28M Mar/2026
Henkel EUR 8.67B 122M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Johnson Matthey GBP 7.02B 1.81B Jun/2026
Linde USD 6.52B 309M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.09B 687M Mar/2026
Novartis USD 9.29B 507M Mar/2026
Nutrien USD 5.67B 1.03B Mar/2026
Philips EUR 3.6B 775M Mar/2026
PPG Industries USD 8.1B 4.64B Mar/2026
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
SAP EUR -4.22B 11.13B Mar/2026
Solvay EUR 1.02B 10M Mar/2026
UCB EUR 2.96B 196M Dec/2025
Umicore EUR 9.97B 1.58B Dec/2025
Vinci EUR 34.12B 2.72B Dec/2025